
Adrenal insufficiency is a rare, chronic and potentially fatal disease, caused by the inability of the adrenal glands to produce sufficient amounts of cortisol, a hormone critical for the correct functioning of the body. From the 3rd of March 2014, Italian patients suffering from this disease, have access to a new treatment: modified-release hydrocortisone, that reproduces the natural variations in the body during the day.
Adrenal insufficiency is a rare, chronic and potentially fatal disease, caused by the inability of the adrenal glands to produce sufficient amounts of cortisol, a hormone critical for the correct functioning of the body. From the 3rd of March 2014, Italian patients suffering from this disease, have access to a new treatment: modified-release hydrocortisone, that reproduces the natural variations in the body during the day.
full press conference


Introduction - Moderator Carlo Gargiulo


What is adrenal insufficiency and which the causes


Symptoms


The new therapy


Specification of the new therapy - 1^


Specification of the new therapy - 2^


Specification of the new therapy - 3^


Patient's point of view - Dr. Lorenzo Sala, Vicepresident A.I.P.Ad


Patients' expectations - Dr. Lorenzo Sala, Vicepresident A.I.P.Ad


A.I.P.Ad Mission and Activities - Dr. Lorenzo Sala, Vicepresident


Conclusion - Moderator Carlo Gargiulo
highlights


The association - Dr. Lorenzo Sala, Vicepresident


A small book of great importance - Dr. Lorenzo Sala, Vicepresident A.I.P.Ad


The new drug: the opion of A.I.P.Ad, Dr. Lorenzo Sala, Vicepresident


A drug for a better quality of life


A disorder not east to diagnose


Viropharma and its mission - Dr. Carlo Sabato, GM Viropharma


Engineered biotecnology for the patient - Dr. Carlo Sabato GM Viropharma

